Compare CHTP to:
After Hours:
2.3087
0.01 (0.38%) 4:24pm ET
| Last Trade: | 2.30 |
|---|---|
| Trade Time: | Nov 25 |
| Change: | |
| Prev Close: | 2.27 |
| Open: | 2.33 |
| Bid: | 2.20 x 300 |
| Ask: | 2.64 x 100 |
| 1y Target Est: | 6.33 |
| Day's Range: | 2.30 - 2.34 |
|---|---|
| 52wk Range: | 1.09 - 7.51 |
| Volume: | 152,126 |
| Avg Vol (3m): | 1,860,890 |
| Market Cap: | 77.05M |
| P/E (ttm): | N/A |
| EPS (ttm): | -0.94 |
| Div & Yield: | N/A (N/A) |
| Thu, Nov 12 | Results From Chelsea Therapeutics' Phase III Trial of Droxidopa in Neurogenic Orthostatic Hypotension to be Presented at 20th Annual International Symposium on the Autonomic Nervous SystemGlobeNewswire |
| Fri, Nov 6 | CHELSEA THERAPEUTICS INTERNATIONAL, LTD. FinancialsEDGAR Online Financials |
| Fri, Nov 6 | Biotech Stock Mailbag: Poniard Predictionsat TheStreet.com |
| Tue, Nov 3 | YRC Worldwide: Midday Volume Moversat TheStreet.com |
| Tue, Nov 3 | Chelsea Just Got Riskier: BioBuzzat TheStreet.com |
| Tue, Nov 3 | The Long Trade in Chelsea Becomes Riskier: BioBuzzat TheStreet.com |
| Mon, Nov 2 | Chelsea Therapeutics International Ltd. Q3 2009 Earnings Call Transcriptat Seeking Alpha |
| Mon, Nov 2 | CHELSEA THERAPEUTICS INTERNATIONAL, LTD. Files SEC form 10-Q, Quarterly ReportEDGAR Online |
| Mon, Nov 2 | Chelsea Therapeutics Reports Third Quarter 2009 ResultsGlobeNewswire |
| Mon, Nov 2 | [$$] 13D Filingsat Barrons.com |
Quotes delayed, except where indicated otherwise.
Delay times are 15 mins for NASDAQ, NYSE and Amex.See also delay times for other exchanges.